Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Spectrum Pharmaceuticals, Inc. SPPI
$1.31
На 18:00, 12 мая 2023
-42.75%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
275081889.00000000
-
week52high
1.57
-
week52low
0.32
-
Revenue
10114000
-
P/E TTM
-2652
-
Beta
2.21072600
-
EPS
-0.45000000
-
Last Dividend
0.15000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley Securities | Buy | Buy | 21 мар 2022 г. |
| H.C. Wainwright | Buy | 26 окт 2020 г. | |
| JMP Securities | Outperform | 17 сент 2020 г. | |
| HC Wainwright & Co. | Buy | Buy | 03 авг 2020 г. |
| Cantor Fitzgerald | Neutral | Neutral | 28 июл 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 12 сент 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 23 сент 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 20 сент 2022 г. |
| B. Riley Securities | Neutral | Buy | 16 ноя 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 28 ноя 2022 г. |
| JMP Securities | Market Outperform | 01 февр 2023 г. | |
| HC Wainwright & Co. | Buy | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Riga Thomas J | D | 1900598 | 107424 | 31 янв 2023 г. |
| McGahan Keith M | D | 645873 | 41014 | 31 янв 2023 г. |
| McGahan Keith M | D | 686887 | 26138 | 30 янв 2023 г. |
| Riga Thomas J | D | 2008022 | 69389 | 30 янв 2023 г. |
| Brennan Nora | A | 840000 | 840000 | 03 янв 2023 г. |
| Brennan Nora | A | 600215 | 240000 | 03 янв 2023 г. |
| McGahan Keith M | A | 778000 | 778000 | 03 янв 2023 г. |
| McGahan Keith M | A | 713025 | 222000 | 03 янв 2023 г. |
| Riga Thomas J | A | 3112000 | 3112000 | 03 янв 2023 г. |
| Riga Thomas J | A | 2077411 | 888000 | 03 янв 2023 г. |
Новостная лента
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 09:56
Spectrum Pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.09 per share a year ago.
7 Hot Penny Stocks Under $1.10 To Watch This Week
PennyStocks
08 мая 2023 г. в 15:18
Penny stocks to buy for under $1 but are they worth the risk? The post 7 Hot Penny Stocks Under $1.10 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy? 4 Under $1.10 To Watch Now
PennyStocks
05 мая 2023 г. в 13:09
Penny stocks to watch this week. The post Best Penny Stocks To Buy?
Spectrum Pharmaceuticals stock pops after Assertio acquires it at a premium
Proactive Investors
25 апр 2023 г. в 11:51
Spectrum Pharmaceuticals (NASDAQ:SPPI) stock is soaring after an all-stock acquisition deal with Assertio Holdings was announced Tuesday morning. The $248 million purchase price values Spectrum shares at $1.14 each, a significant premium over its Tuesday closing price of $0.69.
Why Is Spectrum Pharmaceuticals (SPPI) Stock Up 35% Today?
InvestorPlace
25 апр 2023 г. в 08:27
Spectrum Pharmaceuticals (NASDAQ: SPPI ) stock is soaring higher on Tuesday thanks to an acquisition deal with Assertio (NASDAQ: ASRT ). This deal will have Assertio acquire all outstanding shares of SPPI stock.